| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.0009 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.0009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |